Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-10-060314
Filing Date
2010-11-15
Accepted
2010-11-15 11:09:17
Documents
6
Period of Report
2010-09-30

Document Format Files

Seq Description Document Type Size
1 v201996_10q.htm 10-Q 1611899
2 v201996_ex10-1.htm EX-10.1 31205
3 v201996_ex31-1.htm EX-31.1 10051
4 v201996_ex31-2.htm EX-31.2 10092
5 v201996_ex32-1.htm EX-32.1 5337
6 v201996_ex32-2.htm EX-32.1 5341
  Complete submission text file 0001144204-10-060314.txt   1675514
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10019
Business Address 110 EAST 59TH STREET NEW YORK NY 10019 250-519-0553
BRAINSTORM CELL THERAPEUTICS INC (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 912061050 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-61610 | Film No.: 101189956
SIC: 2836 Biological Products, (No Diagnostic Substances)